NCT00911794View on ClinicalTrials.gov

Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2009

Conditions
Chronic Lung DiseasesCOPDPulmonary Fibrosis
Interventions
OTHER

Disclosure Writing (Written Disclosure Therapy)

Patients write about a stressful life experience

OTHER

Neutral (Sham) Writing

Patients write about neutral subjects

All Listed Sponsors
collaborator

Stony Wold-Herbert Fund, Inc.

OTHER

lead

Winthrop University Hospital

OTHER

NCT00911794 - Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease | Biotech Hunter | Biotech Hunter